antidiabetic drugs การใช้

• Cefalexin also interacts with metformin, an antidiabetic drug,
• "' Phenformin "'is an antidiabetic drug from the biguanide class.
• DPP-4 inhibitors lowered hemoglobin A1C values by 0.74 %, comparable to other antidiabetic drugs.
• Generic formulations are now available in several countries, and metformin is believed to have become the world's most widely prescribed antidiabetic drug.
• Therefore, dapagliflozin reduces the blood glucose concentration with a mechanism that is independent of insulin secretion and sensitivity, unlike many other antidiabetic drugs.
• The antidiabetic drug pioglitazone, in addition to binding to the nuclear receptor PPAR, also has been shown to bind mitoNEET with approximately equal affinity.
• Hydrangeic acid is being investigated as a possible antidiabetic drug as it significantly lowered blood glucose, triglyceride and free fatty acid levels in laboratory animals.
• Bayer said it will launch two new drugs this year, Miglitol, an antidiabetic drug, and Lipobay, used to reduce cholesterol levels in the blood.
• "' Buformin "'( 1-butylbiguanide ) is an oral antidiabetic drug of the biguanide class, chemically related to metformin and phenformin.
• Gluconeogenesis is also a target of therapy for type 2 diabetes, such as the antidiabetic drug, metformin, which inhibits glucose formation and stimulates glucose uptake by cells.
• It showed a synergistic effect with the antidiabetic drug glibenclamide, supporting the possibility of effective combination therapy of glibenclamide and " P . pulmonarius " for diabetes.
• As with other beta blockers, it may interact with calcium channel blockers, catecholamine-depleting drugs, insulin or antidiabetic drugs, beta2-adrenergic agonists, and Clonidine.
• The antidiabetic drug Metformin has been shown to induce a mild and transient inhibition of the mitochondrial respiratory chain complex I, and this inhibition appears to play a key role in its mechanism of action.
• While oral antidiabetic drugs are sometimes used, the only recommended treatment is the use of insulin injections or an insulin pump, and, unlike in type 1 and 2 diabetes, dietary restrictions are not recommended.
• "' Omarigliptin "'( "'MK-3102 "') is a potent, long-acting oral antidiabetic drug of the DPP-4 inhibitor class used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co . It inhibits DPP-4 to increase incretin levels ( GLP-1 and GIP ), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying and decreases blood glucose levels.